跳至主要内容
临床试验/NL-OMON31092
NL-OMON31092尚未招募不适用

ature and mechanism of cognitive deficits following chemotherapy: an (f)MRI study - chemotherapy, cognition and (f)MRI

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • all groups:
  • -sufficient proficiency in the Dutch language;cross-sectional part:
  • -participation in previous neuropsychological study
  • -having been treated with high-dose chemotherapy (CTC);prospective part, experimental group
  • -newly diagnosed breast cancer patients without distant metastases that will receive chemotherapy (ACdd + T);prospective part, control group
  • -newly diagnosed breast cancer patients without distant metastases that will not receive chemotherapy

排除标准

  • -relapse and/or metastases
  • -excessive use of alcohol or drugs
  • -use of psychotropic medication
  • -neurologic or psychiatric disorders that may influence cognitive functioning
  • -conditions that preclude MRI examination

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验

ature and mechanism of cognitive deficits following... | 临床试验